Valuation: CellaVision AB

Market Cap 3.23B 335M 293M 271M 248M 470M 32.28B 478M 1.27B 15.76B 1.26B 1.23B 54.42B P/E 2026 *
23.7x
P/E 2027 * 18.9x
Enterprise Value 3.01B 313M 273M 253M 232M 439M 30.13B 447M 1.18B 14.71B 1.17B 1.15B 50.8B EV / Sales 2026 *
3.97x
EV / Sales 2027 * 3.5x
Free-Float
83.08%
Yield 2026 *
2.03%
Yield 2027 * 2.36%
1 day+3.78%
1 month+3.78%
3 months-13.23%
6 months-17.65%
Current year-16.80%
1 month 14
Extreme 14
14
Current year 13.49
Extreme 13.49
17.3
1 year 13.49
Extreme 13.49
17.3
3 years 13.49
Extreme 13.49
25.9
5 years 13.49
Extreme 13.49
34.75
10 years 13.49
Extreme 13.49
41.48
Manager TitleAgeSince
Chief Executive Officer - 05/06/2026
Director of Finance/CFO 46 02/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 04/05/2018
Chairman 64 29/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
+3.78%-.--% - - 335M
-0.16%+5.87%+17.90%-19.73% 17.63B
-3.55%+2.88%+17.43%+95.22% 1.73B
+0.30%+4.13%-34.13%-78.15% 1.24B
-1.19%-7.28%-38.03%+13.79% 1.02B
+1.98%+8.94%-24.06%-50.67% 659M
+2.44%+6.67%-36.74%-54.14% 562M
+1.39%+0.88%+39.29%-52.49% 455M
+0.47%+3.08%-52.89%-58.27% 385M
-3.29%+13.25%+43.55% - 341M
Average +0.25%+3.64%-7.52%-25.56% 2.67B
Weighted average by Cap. -0.27%+9.43%+10.00%-15.86%

Financials

2026 *2027 *
Net sales 760M 78.86M 68.93M 63.75M 58.5M 111M 7.6B 113M 299M 3.71B 296M 290M 12.81B 851M 88.23M 77.12M 71.32M 65.45M 124M 8.5B 126M 334M 4.15B 331M 324M 14.33B
Net income 136M 14.15M 12.37M 11.44M 10.49M 19.86M 1.36B 20.2M 53.57M 666M 53.12M 51.96M 2.3B 175M 18.15M 15.87M 14.67M 13.47M 25.48M 1.75B 25.93M 68.75M 854M 68.17M 66.67M 2.95B
Net Debt -215M -22.32M -19.51M -18.04M -16.55M -31.33M -2.15B -31.88M -84.52M -1.05B -83.81M -81.97M -3.63B -254M -26.33M -23.02M -21.29M -19.53M -36.97M -2.54B -37.61M -99.72M -1.24B -98.89M -96.71M -4.28B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
241
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
135.40SEK
Average target price
171.25SEK
Spread / Average Target
+26.48%

Quarterly revenue - Rate of surprise